PRESS RELEASE published on 01/24/2024 at 14:00, 2 years ago AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
PRESS RELEASE published on 09/28/2023 at 14:00, 2 years 4 months ago AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
PRESS RELEASE published on 08/23/2023 at 14:00, 2 years 5 months ago AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
PRESS RELEASE published on 07/06/2023 at 14:00, 2 years 7 months ago AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
PRESS RELEASE published on 04/04/2023 at 14:00, 2 years 10 months ago AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Published on 02/18/2026 at 15:15, 3 hours 46 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 4 hours 1 minute ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 4 hours 36 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 5 hours 1 minute ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 5 hours 1 minute ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 18:54, 7 minutes ago EQS-Adhoc: flatexDEGIRO SE: Management and Supervisory Board adopt new capital allocation policy; dividend increase to 20% of Net Income targeted; FY 2025 guidance slightly exceeded
Published on 02/18/2026 at 18:21, 39 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/18/2026 at 18:00, 1 hour 1 minute ago E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026
Published on 02/18/2026 at 17:58, 1 hour 3 minutes ago 2CRSi SA: 2CRSi initiates, within the ÆTHER Infrastructure consortium, an exclusive negotiation for the establishment of a strategic industrial site dedicated to AI Gigafactories
Published on 02/18/2026 at 17:58, 1 hour 3 minutes ago 2CRSi SA: 2CRSi initie, au sein du consortium ÆTHER Infrastructure, une négociation exclusive pour l’implantation d’un site industriel stratégique dédié aux AI Gigafactories
Published on 02/18/2026 at 18:00, 1 hour 1 minute ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Published on 02/18/2026 at 18:00, 1 hour 1 minute ago Outstanding Shares and Voting Rights Statement at 31 January 2026
Published on 02/18/2026 at 17:40, 1 hour 21 minutes ago GROUPE ES - Communiqué sur les résultats 2025
Published on 02/18/2026 at 13:45, 5 hours 16 minutes ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
